My lab is hiring! We are looking for a Research Assistant to characterize the function of a schizophrenia risk factor at @AberdeenNeuro. Involves iPSC, gene editing and neuronal biology! The post is available either full-time or part-time.
https://t.co/KEygxT4gtM
The Authors show that chromatin targeting of RNF12 is required for substrate ubiquitylation and transcriptional responses, providing insight into mechanisms by which ubiquitylation regulates gene expression @gregfindlaylab@mrcppu
https://t.co/LKnI1P0X8u
We are #recruiting a #postdoc for a new and exciting project defining new targets in #neurodegenerative disease and which we have developed with a major pharmaceutical company. See link for job info. Please re-tweet. #ALS#MND#dementia#Parkinsons
https://t.co/q3vcEuBzh6
Exciting Wellcome Trust-funded postdoc positions available in our lab to understand how #signalling is disrupted in #intellectualdisability. Come join us and learn cool methods in #massspectrometry and #stemcell biology. Apply here by 31st August;
https://t.co/gB4QSpTF1F
Transitioning towards independence in an academic career while juggling family commitments comes with many challenges. Thank you @petrouliet @DanielErsk1ne @gregfindlaylab @ClaireDurrant1 for the open and honest conversation #ARUKConf23
Exciting Wellcome Trust-funded postdoc positions available in our lab to understand how #signalling is disrupted in #intellectualdisability. Come join us and learn cool methods in #massspectrometry and #stemcell biology
https://t.co/pbuaM4FZLv
Exciting Wellcome Trust-funded postdoc positions available in our lab to understand how #signalling is disrupted in #intellectualdisability. neurodegeneration models. Come join us and learn cool methods in #massspectrometry and #stemcell biology
https://t.co/pbuaM4FZLv
My lab is hiring a CRUK-funded postdoc to work on ERphagy in cancer progression! https://t.co/nq2ELOBHWR We are looking for candidates with cancer/cell biology expertise. There is also another upcoming postdoc position to work more broadly on other aspects of ER QC (1/2)